PharmaZell develops and produces pharmaceutical active ingredients (API), provides services for formulation development, and compiles required regulatory documents for both the originator and generic pharmaceutical industry. Being a German enterprise with multinational development and production sites as well as a globally acting sales organization they are a long lasting reliable and stable partner for their customers on all continents. They develop tailor-made solutions based on a broad and flexible technology platform together with their customers striving to solve their problems efficiently and with full commitment. PharmaZell follows ethical principles and acts responsibly caring about the environment, their business partners and employees.

Tokyo Tanabe Co. Ltd., a subsidiary of Cegedim SA, is a Japanese company located in Tokyo. The firm produces and sells medicines.

Erregierre SpA manufactures and supplies ingredients for pharmaceutical use. Its services include knoevenagel, aldol reaction, malonic, hantzsch synthesis, diazotizations, nitrations, oxidations and halogenations. The company was founded in 1974 and is headquartered in San Paolo d'Argon, Italy.

HighTide Therapeutics is a global clinical-stage biopharmaceutical company focused on discovering and developing novel drugs to treat chronic liver diseases, gastrointestinal diseases and metabolic disorders with high unmet needs. The company integrates expertise in disease biology, medicinal chemistry, clinical development and regulatory affairs to advance its growing pipeline of drugs. The company’s lead drug candidate, HTD1801, is a first-in-class new molecular entity, currently in Phase II trials for the treatment of primary sclerosing cholangitis (PSC), and nonalcoholic steatohepatitis (NASH). The FDA has granted HTD1801 Fast Track Designation in both diseases. HighTide Therapeutics was established in 2011 by Liping Liu in Shenzhen, Guangdong.

Terumo is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare.

Dr. Falk Pharma GmbH engages in the development and sale of medication for indications in hematology and gastroenterology in Germany and internationally. The company principally offers prescription drugs that are used in treating inflammatory bowel diseases, cholestatic liver diseases, irritable bowel syndromes, and constipation, as well as for colon cleansing prior to colonoscopies. It also organizes and sponsors medical education events; and offers publications for healthcare professionals, as well as for patients and their families. The company was formerly known as Dr. Falk Arzneimittel GmbH & Co KG and changed its name to Dr. Falk Pharma GmbH in 1989. Dr. Falk Pharma GmbH was founded in 1960 and is headquartered in Freiburg, Germany

Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.

Daewoong Pharmaceutical Co., Ltd (Korean: 대웅제약) is a Seoul, South Korea-based bioengineering company operating as a subsidiary of Daewoong Co., Ltd., a global health care group. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products in South Korea, including prescription and over-the-counter healthcare products.

Roussel UCLAF.

Medichem SA is a Spanish company located in Sant Joan Despi that manufactures and supplies pharmaceutical ingredients. The firm was founded in 1972. José Luis Rodríguez is the CEO, in this role since 1996.

Hongboyuan Life Technology (Shenzhen) Co., Ltd., established on 2017-07-14, Business scope includes general business items:Research and development and technical services of biological enzyme catalytic products;Invest in business(Specific projects will be reported separately);Economic Information Consulting(No Securities,Insurance,fund,bank,Financial business and other restricted items);Business Management Consulting(Does not include talent intermediary services).(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating)Engaged in technology development in the field of biotechnology,technical consulting,Technical Services,technology transfer;Operating import and export business(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating);cosmetic,beauty products(Does not contain drugs,medical instruments),Sales of daily necessities;Business Consulting(No restricted items);Health and wellness management consulting(Does not contain medical behavior);Conference planning;Exhibition planning;marketing planning;Do business online(No restricted items);Network Technology Technical Services;Class I medical device,Sales of Fitness Equipment;Tourist Information Consultation.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments),The licensing program is:Sales of prepackaged food.Radio and television program production and management.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Zhongshan Bailing Biotechnology Co., Ltd. is a private company headquartered in Zhongshan, China. The firm engages in the development, manufacturing and distribution of pharmaceutical products.

Disphar International offers generic and value-added pharmaceutical products and development, licensing out of pharmaceutical products.

Daewoong Co., Ltd. engages in the management of its subsidiaries. It provides management and consultant services to its subsidiaries. The company was founded by Yoon Young-Hwa on January 10, 1961 and is headquartered in Seongnam, South Korea.

Yakult Honsha Co., Ltd. engages in the manufacture and sale of food and beverage products, cosmetics, and pharmaceuticals. It operates through the following segments: Food and Beverages in Japan, the Americas, Asia and Oceania, and Europe; Pharmaceuticals, and Others. The Food and Beverages segment produces and merchandises milk drinks, noodles, juices, and soft drinks. The Pharmaceuticals segment manufactures and sells anti-cancer drugs and other pharmaceutical products. The Others segment includes cosmetics and professional baseball team management. The company was founded by Minoru Shirota in 1935 and is headquartered in Tokyo, Japan.

Shilpa Medicare Ltd. engages in the manufacturing of pharmaceutical products and wind power generation. The company was founded on November 20, 1987 and is headquartered in Raichur, India.

Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals. Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals.” In accordance with this philosophy, as we implement our business activities we strive to realize our vision, which expresses that “Mitsubishi Tanabe Pharma strive to be a global research-driven pharmaceutical company that is trusted by communities.” As a company that is trusted and highly evaluated by patients and health care professionals as well as by society and shareholders, we will implement management with a focus on transparency and fairness while always keeping in mind the starting point of our business activities: “Everything we do is for the patients.”

Sandoz AG, part of Novartis AG, is a company headquartered in Basel, Switzerland, that develops generic medicines and biosimilars.

Develops medicines and healthcare products using polymer technologies